Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate and Denosumab

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: Denosumab Bisphosphonate CONDITION: Glucocorticoid‐Induced Osteoporosis PRIMARY OUTCOME: Percent change in bone mineral density of the lumbar spine SECONDARY OUTCOME: Safety, Incident vertebral fracture, bone mineral density of the femoral neck, bone makers INCLUSION CRITERIA: Glucocorticoid administered. Less than 80% (%YAM) of bone mineral density at the lumber spine or femoral neck, or presence of fragile fracture at the spine.
Epistemonikos ID: 87b70287880097b86e5e586328b1aa8023f0b479
First added on: Aug 22, 2024